Authors
Latest:
Consider Interactions With Analgesics When Treating NeuropathiesClinicians should weigh the risks and benefits of each medication to ensure effective and safe care.
Latest:
Rx Product News: Profile: A Closer Look at New FDA Actions: NuvigilThis single, longer-acting R-enantiomer of the racemic modafinil has been approved as a wakefulness-promoting drug.
Latest:
Smart Trap Could Lower Spread of Zika, West Nile MosquitoesTraps help entomologists track mosquitoes that are carrying Zika or other harmful diseases.
Latest:
Managing Care and Costs for Orphan ConditionsThe number of drugs approved for orphan conditions has increased in recent years, and specialty pharmacies play an important role in the management of therapies for patients with rare diseases.
Latest:
Adherence and Persistence of Bimatoprost in Prior Latanoprost UsersA new ophthalmic formulation of bimatoprost was found to improve adherence and persistence compared with the original formulation of bimatoprost.
Latest:
Variations in The Specialty Pharmacy Hub ModelAlthough many hubs offer similar services, no two specialty pharmacy hubs and no two hub programs are entirely alike.
Latest:
Drivers of Change in Pharmacy Benefit ManagementExecutive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.
Latest:
Payment for Pharmacists’ Care: Pulling the LinchpinThe emergence of a new Medicare Advantage plan, Troy Medicare, offers much needed momentum to drive pharmacists’ services.
Latest:
Navigating the World of Vaccine BillingOnce the basics of vaccine billing are understood, pharmacists can easily take advantage of this growth opportunity.
Latest:
Pharmacy Accreditation 101Best strategies to help the pharmacy department get ready for a survey and stay ready.
Latest:
Community Pharmacist Involvement in Prescription Drug Monitoring ProgramsThe involvement of community pharmacists is vital to reduce prescription drug abuse through the use of Electronic Prescription Drug Monitoring Programs.
Latest:
Obesity Management: Quality of Life, Cost Impact, and Disease BurdenRecognizing the health and economic burden associated with obesity to evaluate options and identify strategies.
Latest:
Atezolizumab and Nab-Paclitaxel for the Treatment of Triple-Negative Breast CancerCompared with other breast cancer subtypes, TNBC is more likely to be diagnosed in younger women and is more likely to have metastases present at the time of diagnosis.
Latest:
Federal Government Funds Two-Thirds of Health Care Costs, Study FindsContrary to popular perceptions that health care financing in the US is predominantly private, Americans pay the world
Latest:
Insurance Claims May Model Anti-HER2 Chemo DemandA study including 10 million patients covered by 11 health plans suggested that insurance claims could be used to estimate the number of early-stage breast cancer cases as well as the demand for anti-HER2 drugs.
Latest:
Can Large Doses of Folic Acid Relieve Migraines?Migraine is the third most prevalent illness in the world, affecting 1 billion individuals worldwide.
Latest:
Impact of L-Methylfolate Combination Therapy Among Diabetic Peripheral Neuropathy PatientsPatients with diabetic peripheral neuropathy taking L-methylfolate, pyridoxal-5'-phosphate, and methylcobalamin (MPM) had lower all-cause hospitalization risk and healthcare costs than patients not taking MPM.
Latest:
Claims Data Analysis of Dosing and Cost of TNF AntagonistHigher drug costs may be attributable to either high initial doses or a dose increase.
Latest:
Personalized Therapy: A Note from the Editor-in-Chief of Pharmacy TimesAs pharmacogenomics continues to progress, specialty pharmacists may dominate treatment for certain diseases.
Latest:
Capecitabine and Warfarin Interaction: A Review of Literature and RecommendationsThe capecitabine and warfarin interaction is well documented in the literature and has earned a black box warning because of its potential severity.
Latest:
MRPs Are Both a Blessing and a CurseMandated medical review panels can help health care professionals but hinder patients who file malpractice suits.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Hemostasis and Thrombosis IssuesNews in the world of anticoagulation is presented, including insights on the new guidelines for warfarin.
Latest:
Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification SystemA controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.
Latest:
Landmark Supreme Court Ruling: State Regulation of PBM Reimbursement RatesSupreme Court ruling clears the way for states to pass laws that protect pharmacies from predatory reimbursement practices by PBMs.
Latest:
340B and the Medicare Cost ReportCertain institutional providers are required to file a Medicare cost report annually to CMS, which uses that information to set prospective payment rates and determine if Medicare overpaid or underpaid a given institution during the submitted fiscal year.
